Massachusetts Financial Services
BIOA

Massachusetts Financial Services’s BioAge Labs BIOA Stock Holding History

Massachusetts Financial Services’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
18,090
+35
+0.2% +$632 ﹤0.01% 957
2026
Q1 		$316K Buy
+18,055
New +$348K ﹤0.01% 917

Other funds holding BIOA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services's BIOA Position: Q2 2026 in Review

Massachusetts Financial Services increased its BioAge Labs (BIOA) stake by 0.19% in Q2 2026, buying an estimated $632 and bringing the position to 18,090 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Massachusetts Financial Services first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Massachusetts Financial Services held 18,090 shares of BioAge Labs worth $443K as of Q2 2026.
  • Massachusetts Financial Services bought 35 BioAge Labs shares in Q2 2026, an estimated $632.
  • BioAge Labs made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #957 holding.
  • Massachusetts Financial Services first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • 37 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.